PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business. The image analysis algorithms will be deployed on Roche's...

From HIT Consultant regarding PathAI: What You Should Know: PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. The expansion...

Driving Quality and Efficiency in Digital Pathology Workflows with AI-Enabled Tumor Assessment Boston, MA – December 14, 2023 – PathAI, a global leader in AI-powered pathology, today announced TumorDetect on AISightTM, PathAI’s...

PathAI: The four research posters demonstrate the efficacy and utility of AI-powered digital pathology in tissue samples from individuals with metabolic dysfunction-associated steatohepatitis Boston, MA | November 10, 2023, 10:00 AM...

PathAI: The test allows for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). It will be announced at the American College...

PathAI: The three research posters demonstrate how artificial intelligence may improve the research and clinical utility of various biomarker programs Boston, MA | October 11, 2023 10:00 AM Eastern Daylight Time - PathAI, a global leader...